Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mowbray

Showing results (641-650 of 690) with videos related to

Pageof 69
Sort By:
ACS Infectious Diseases|March 14, 2022
The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease OutbreaksKirandeep Samby, Dominique Besson, Anirban Dutta, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonistCharles E Mowbray, Andrew S Bell, Nicholas P Clarke, et al.
Biochimica Et Biophysica Acta|July 10, 2003
Cel6A, a major exoglucanase from the cellulosome of the anaerobic fungi Piromyces sp. E2 and Piromyces equiHarry R Harhangi, Alexander C J Freelove, Wimal Ubhayasekera, et al.
Nature Communications|February 16, 2022
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concernRana Abdelnabi, Caroline S Foo, Dirk Jochmans, et al.
Resuscitation|June 24, 2021
Prognostic association of frailty with post-arrest outcomes following cardiac arrest: A systematic review and meta-analysisFabrice I Mowbray, Donna Manlongat, Rebecca H Correia, et al.
Heliyon|May 28, 2024
Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patternsPaul-Rémi Petit, Franck Touret, Jean-Sélim Driouich, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 7, 2025
Physical and Occupational Therapist Evaluations for Fall Prevention in the Emergency Department: A Geriatric ED Guidelines 2.0 Systematic ReviewLauren T Southerland, Pedro K Curiati, Richard D Shih, et al.
Cancer|September 26, 2019
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and researchMolly McFatrich, Jennifer Brondon, Nicole R Lucas, et al.
Journal of Medicinal Chemistry|July 4, 2013
DXR inhibition by potent mono- and disubstituted fosmidomycin analoguesAnna M Jansson, Anna Więckowska, Christofer Björkelid, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR)M Abid Masood, Matthew D Selby, Andrew S Bell, et al.
Pageof 69

Showing results (641-650 of 690) with videos related to

Sort By:
Pageof 69
ACS Infectious Diseases|March 14, 2022
The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease OutbreaksKirandeep Samby, Dominique Besson, Anirban Dutta, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonistCharles E Mowbray, Andrew S Bell, Nicholas P Clarke, et al.
Biochimica Et Biophysica Acta|July 10, 2003
Cel6A, a major exoglucanase from the cellulosome of the anaerobic fungi Piromyces sp. E2 and Piromyces equiHarry R Harhangi, Alexander C J Freelove, Wimal Ubhayasekera, et al.
Nature Communications|February 16, 2022
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concernRana Abdelnabi, Caroline S Foo, Dirk Jochmans, et al.
Resuscitation|June 24, 2021
Prognostic association of frailty with post-arrest outcomes following cardiac arrest: A systematic review and meta-analysisFabrice I Mowbray, Donna Manlongat, Rebecca H Correia, et al.
Heliyon|May 28, 2024
Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patternsPaul-Rémi Petit, Franck Touret, Jean-Sélim Driouich, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 7, 2025
Physical and Occupational Therapist Evaluations for Fall Prevention in the Emergency Department: A Geriatric ED Guidelines 2.0 Systematic ReviewLauren T Southerland, Pedro K Curiati, Richard D Shih, et al.
Cancer|September 26, 2019
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and researchMolly McFatrich, Jennifer Brondon, Nicole R Lucas, et al.
Journal of Medicinal Chemistry|July 4, 2013
DXR inhibition by potent mono- and disubstituted fosmidomycin analoguesAnna M Jansson, Anna Więckowska, Christofer Björkelid, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR)M Abid Masood, Matthew D Selby, Andrew S Bell, et al.
Pageof 69